CARMILA: Resources devoted to the liquidity contract as of 30 June 2023
08 7월 2023 - 12:50AM
Business Wire
Regulatory News:
At 30 June 2023, resources made available for the liquidity
agreement concluded by Carmila with Exane BNP Paribas were the
following:
- 102,756 CARMILA shares;
- Euro 1,279,923.
During the 1st half-year of 2023, it has been negotiated a total
of:
- For purchase, 186,400 shares, for a total amount of Euro
2,614,279 (1,226 transactions);
- For sale, 189,670 shares, for a total amount of Euro 2,676,992
(1,222 transactions).
For information, at the time of the last assessments, available
resources were:
1. At the time of the previous half-yearly assessment at
December 31, 2022, available resources were:
- 106,026 CARMILA shares;
- Euro 1,217,210.
2. During the 2nd half-year of 2022, it has been negotiated a
total of:
- For purchase, 565,330 shares, for a total amount of Euro
8,079,132 (3,185 transactions);
- For sale, 536,313 shares, for a total amount of Euro 7,760,524
(3,170 transactions).
3. As of July 1st, 2021, date of implementation of the AMF
decision n°2021-01 dated June 22, 2021, the following resources
were:
- 112,910 CARMILA shares ;
- Euro 991,074.
4. As of December 31, 2018, date of implementation of the AMF
decision n°2018-1 dated July 2, 2018, the following resources
were:
- 203,848 CARMILA shares;
- Euro 743,970.
*withdrawal of 102,358 shares on July 1st, 2019.
INVESTOR AGENDA
25 July 2023 (after market close): First-half 2023
results 26 July 2023: First-half 2023 results presentation
20 October 2023 (after market close): Third-quarter 2023
financial information
ABOUT CARMILA
As the third-largest listed owner of commercial property in
Europe, Carmila was founded by Carrefour and large institutional
investors in order to transform and enhance the value of shopping
centres adjoining Carrefour hypermarkets in France, Spain and
Italy. At 31 December 2022, its portfolio was valued at €6.2
billion, comprising 208 shopping centres, all leaders in their
catchment areas.
Carmila is listed on Euronext-Paris Compartment A under the
symbol CARM. It benefits from the tax regime for French real estate
investment trusts (“SIIC”).
Carmila has been a member of the SBF 120 since 20 June 2022.
Important notice
Some of the statements contained in this document are not
historical facts but rather statements of future expectations,
estimates and other forward-looking statements based on
management’s beliefs. These statements reflect such views and
assumptions prevailing as of the date of the statements and involve
known and unknown risks and uncertainties that could cause future
results, performance or events to differ materially from those
expressed or implied in such statements. Please refer to the most
recent Universal Registration Document filed in French by Carmila
with the Autorité des marchés financiers for additional information
in relation to such factors, risks and uncertainties. Carmila has
no intention and is under no obligation to update or review the
forward-looking statements referred to above. Consequently, Carmila
accepts no liability for any consequences arising from the use of
any of the above statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230707796009/en/
INVESTOR AND ANALYST CONTACT Jonathan Kirk – Head of
Investor Relations jonathan_kirk@carmila.com +33 6 31 71 83 98
PRESS CONTACT Elodie Arcayna – Corporate Communications
Director elodie_arcayna@carmila.com
+33 7 86 54 40 10
Carisma Therapeutics (NASDAQ:CARM)
과거 데이터 주식 차트
부터 9월(9) 2024 으로 10월(10) 2024
Carisma Therapeutics (NASDAQ:CARM)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024